Rivaroxaban Completed Phase 1 Trials for Therapeutic Equivalency

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01436526Bioequivalence Study in Healthy Subjects, 2*5 mg Tablets Rivaroxaban Versus 1*10 mg Tablet Rivaroxaban